Policy | 28 September 2026
Department of Pharmaceuticals Secretary pointed to the experience of the US and China, where stronger links between industry and public research institutions have supported innovation
The move comes against the backdrop of continuing concerns over the sale of Schedule H, H1 and X medicines without valid prescriptions
Siddhartha Bhattacharya says procurement cost alone cannot reflect the true cost of safely delivering complex medical technologies to patients
Gujarat, Uttar Pradesh, Madhya Pradesh, and Mizoram have achieved 100 per cent coverage of their respective identified target populations
The conference aligns with the Government of India’s Biopharma SHAKTI Vision to strengthen India’s biopharmaceutical ecosystem through innovation, self-reliance, quality, and global competitiveness
The event organised by CSIR under the guidance of the Office of the Principal Scientific Adviser to the Government of India will be graced by three Nobel Laureates, Prof. Joachim Frank, Sir Richard J. Roberts and Prof. Kostya Novoselov
The delegation held discussions with senior company executives on potential areas of collaboration, including international market access, technical exchange and the development of healthcare solutions for global markets
Dr. Ranga Chandrashekhar, Joint Drug Controller, CDSCO has underscored that regulator is reviewing drug approval pathway to identify areas where intervention can be reduced while maintaining necessary safeguards
Union minister said technologies should not reach commercialisation only to discover that modifications are required to meet actual user requirements
Pharma sector must lead in R&D, new molecules, biosimilars and biotech
According to figures shared during the Mumbai engagement, Gujarat accounts for around 18% of India's pharmaceutical sector, while the state has a 16% share in pharmaceutical manufacturing
Planned as a recurring platform, the future editions are proposed across different cities to connect regional biotechnology innovation ecosystems with investment networks
The company remains in active negotiations with the Trump Administration and is seeking a deal built around all four of President Trump’s drug-pricing priorities
Health Ministry reviews malaria elimination strategy with focus now on remaining 33 high-burden districts to achieve SDG target of ending malaria by 2030
Indian Pharmacopoeia Commission introduces seven phytochemical and five botanical reference standards at Northeast conclave
Rs. 5,000-crore scheme invites applications from startups, MSMEs and industry across new medicines, biosimilars, novel medical devices and other priority areas
The union minister highlighted India's growing role in global healthcare and the potential of artificial intelligence (AI) to transform drug discovery, diagnostics and patient care
The conference provided a platform for knowledge sharing, networking and collaboration aimed at promoting a ‘whole-of-government’ approach and reducing organisational silos
Health Ministry reviews ILI/SARI trends, testing, hospital capacity and critical-care readiness in Delhi and across India
Subscribe To Our Newsletter & Stay Updated
